Frontlight ResearchEarly access
Trial site
Cancer Research South Australia
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Prostate cancer4 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 12 trials
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Amgen3 trials
- BeiGene3 trials
- Bayer1 trial
- Boehringer Ingelheim1 trial
- Immuneering Corporation1 trial
- and 3 more
Running trials
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Prostate cancer2 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Terminated
Completed
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
Site data: ClinicalTrials.govUpdated 14 Nov 2026